CEO: Antoniu Fantana
Visit Website

Although premature babies are now kept alive at an increasing rate, disability rates and positive long-term outcomes have not significantly improved. Many common complications begin in the brain, such as a 40% risk of bleeding or hemorrhaging. 149 Medical is developing the first non-invasive brain monitor that measures real-time brain hemodynamics and metabolism in preterm newborns, second by second. It will provide early actionable alerts and continuous feedback allowing for early intervention and treatment monitoring. They expect that their device will change the standard of care by improving lives, reducing medical errors, and reducing overall healthcare costs.